The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Maddock, Helen, Professor
    University Lecturer born in December 1970
    Individual (1 offspring)
    Officer
    2013-12-17 ~ now
    OF - Director → CIF 0
    Professor Helen Maddock
    Born in December 1970
    Individual (1 offspring)
    Person with significant control
    2018-12-19 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Billson, Jeremy Paul, Dr
    Ceo born in December 1966
    Individual (2 offsprings)
    Officer
    2015-11-23 ~ now
    OF - Director → CIF 0
  • 3
    Noon, Paul David
    Pro-Vice-Chancellor For Enterprise & Innovation born in June 1968
    Individual (5 offsprings)
    Officer
    2017-04-20 ~ now
    OF - Director → CIF 0
  • 4
    COVENTRY UNIVERSITY ENTERPRISES LIMITED - now
    COVENTRY POLYTECHNIC ENTERPRISES LIMITED - 1992-07-10
    The Technocentre, Priory Street, Coventry, England
    Active Corporate (6 parents, 8 offsprings)
    Person with significant control
    2018-12-19 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 5
  • 1
    Wallis, Robert Michael, Dr
    Safety Pharmacology Consultant born in September 1955
    Individual (1 offspring)
    Officer
    2013-12-20 ~ 2022-04-18
    OF - Director → CIF 0
  • 2
    Francis, Timothy, Dr
    Ipr Commercialisation Manager born in August 1978
    Individual
    Officer
    2013-06-18 ~ 2013-06-19
    OF - Director → CIF 0
  • 3
    Soutter, David George Michael
    Deputy Vice-Chancellor born in November 1955
    Individual (1 offspring)
    Officer
    2013-06-18 ~ 2017-04-20
    OF - Director → CIF 0
  • 4
    Forward House, 17 High Street, Henley-in-arden, Warwickshire, England
    Active Corporate (6 parents, 63 offsprings)
    Officer
    2013-12-20 ~ 2018-08-14
    PE - Director → CIF 0
  • 5
    MERCIA ASSET MANAGEMENT PLC - now
    Forward House, 17 High Street, Henley-in-arden, England
    Active Corporate (7 parents, 8 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-12-19
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
parent relation
Company in focus

INOCARDIA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
0 GBP2023-09-30
6,621 GBP2022-09-30
Debtors
2,276 GBP2023-09-30
35,667 GBP2022-09-30
Cash at bank and in hand
136,041 GBP2023-09-30
43,221 GBP2022-09-30
Equity
Called up share capital
109 GBP2023-09-30
109 GBP2022-09-30
Share premium
529,856 GBP2023-09-30
529,856 GBP2022-09-30
Retained earnings (accumulated losses)
-23,010 GBP2023-09-30
86,123 GBP2022-09-30
Average Number of Employees
32022-10-01 ~ 2023-09-30
42021-10-01 ~ 2022-09-30
Director Remuneration
34,830 GBP2022-10-01 ~ 2023-09-30
82,792 GBP2021-10-01 ~ 2022-09-30
Intangible Assets - Gross Cost
Development expenditure
785,784 GBP2023-09-30
722,219 GBP2022-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
90,277 GBP2023-09-30
0 GBP2022-09-30
Intangible Assets - Increase From Amortisation Charge for Year
Development expenditure
90,277 GBP2022-10-01 ~ 2023-09-30
Intangible Assets
Development expenditure
695,507 GBP2023-09-30
722,219 GBP2022-09-30
Property, Plant & Equipment - Gross Cost
Other
73,572 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
73,572 GBP2023-09-30
66,951 GBP2022-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
6,621 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment
Other
0 GBP2023-09-30
6,621 GBP2022-09-30
Amount of corporation tax that is recoverable
Current
0 GBP2023-09-30
32,735 GBP2022-09-30
Other Debtors
Amounts falling due within one year
2,276 GBP2023-09-30
2,932 GBP2022-09-30
Debtors
Current, Amounts falling due within one year
2,276 GBP2023-09-30
35,667 GBP2022-09-30
Trade Creditors/Trade Payables
Current
18,958 GBP2023-09-30
8,265 GBP2022-09-30
Other Taxation & Social Security Payable
Current
935 GBP2023-09-30
7,442 GBP2022-09-30
Other Creditors
Current
306,976 GBP2023-09-30
175,933 GBP2022-09-30
Creditors
Current
326,869 GBP2023-09-30
191,640 GBP2022-09-30
Equity
Called up share capital
109 GBP2023-09-30
109 GBP2022-09-30
  • INOCARDIA LIMITED
    Info
    Registered number 08573417
    Technocentre, Puma Way, Coventry CV1 2TT
    Private Limited Company incorporated on 2013-06-18 (12 years). The company status is Active.
    The last date of confirmation statement was made at 2024-06-18
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.